Convalescent plasma for patients with multiple myeloma and COVID-19; the European Myeloma Network consensus
Leukemia, Published online: 28 July 2023; doi:10.1038/s41375-023-01974-1Convalescent plasma for patients with multiple myeloma and COVID-19; the European Myeloma Network consensus (Source: Leukemia)
Source: Leukemia - July 28, 2023 Category: Hematology Authors: Evangelos Terpos Pellegrino Musto Monika Engelhardt Ioannis Ntanasis-Stathopoulos Pieter Sonneveld Heinz Ludwig Source Type: research
Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells
Leukemia, Published online: 26 July 2023; doi:10.1038/s41375-023-01972-3Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells (Source: Leukemia)
Source: Leukemia - July 26, 2023 Category: Hematology Authors: Anna Palau Filip Segerberg Michael Lidschreiber Katja Lidschreiber Aonghus J. Naughton Maria Needhamsen Lisa Anna Jung Maja Jagodic Patrick Cramer S ören Lehmann Mattias Carlsten Andreas Lennartsson Source Type: research
Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression)
Leukemia, Published online: 26 July 2023; doi:10.1038/s41375-023-01977-yClinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression) (Source: Leukemia)
Source: Leukemia - July 26, 2023 Category: Hematology Authors: Gabriel Scheubeck Linmiao Jiang Olivier Hermine Hanneke C. Kluin-Nelemans Christian Schmidt Michael Unterhalt Andreas Rosenwald Wolfram Klapper Andrea Evangelista Marco Ladetto Mats Jerkeman Simone Ferrero Martin Dreyling Eva Hoster Source Type: research
Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia
Leukemia, Published online: 25 July 2023; doi:10.1038/s41375-023-01971-4Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia (Source: Leukemia)
Source: Leukemia - July 25, 2023 Category: Hematology Authors: Ayuna Hattori Emi Takamatsu-Ichihara Yoshiki Yamamoto Shuhei Fujita Kazutsune Yamagata Takuo Katsumoto Yukino Machida Haruka Shinohara Ryo Murakami Issay Kitabayashi Source Type: research
Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis
Leukemia, Published online: 21 July 2023; doi:10.1038/s41375-023-01975-0Prognosis of IGLV3-21R110 chronic lymphocytic leukemia after chemotherapy-based treatment in a real-world analysis (Source: Leukemia)
Source: Leukemia - July 21, 2023 Category: Hematology Authors: Paul J. Hengeveld Hendrik Veelken Cornelis A. M. van Bergen Edwin Quinten Mischa Y. L. Vervoordeldonk Wahija Ismailzada Rob S. Barendse Julie M. N. Dubois Marinus H. J. van Oers Christian H. Geisler Arnon P. Kater Peter E. Westerweel Anton W. Langerak Mar Source Type: research
Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery?
Leukemia, Published online: 20 July 2023; doi:10.1038/s41375-023-01973-2Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery? (Source: Leukemia)
Source: Leukemia - July 20, 2023 Category: Hematology Authors: Junren Chen Robert Peter Gale Yahui Feng Yu Hu Saibing Qi Xueou Liu Huaiping Zhu Xiaowen Gong Wei Zhang Huilan Liu Zimin Sun Source Type: research
Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748
Leukemia, Published online: 19 July 2023; doi:10.1038/s41375-023-01962-5Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748 (Source: Leukemia)
Source: Leukemia - July 19, 2023 Category: Hematology Authors: Rita Alaggio Catalina Amador Ioannis Anagnostopoulos Ayoma D. Attygalle Iguaracyra Barreto de Oliveira Araujo Emilio Berti Govind Bhagat Anita Maria Borges Daniel Boyer Mariarita Calaminici Amy Chadburn John K. C. Chan Wah Cheuk Wee-Joo Chng John K. Choi Source Type: research
Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages
Leukemia, Published online: 19 July 2023; doi:10.1038/s41375-023-01965-2Pharmacological inhibition of METTL3 impacts specific haematopoietic lineages (Source: Leukemia)
Source: Leukemia - July 19, 2023 Category: Hematology Authors: Katherine Sturgess Eliza Yankova M. S. Vijayabaskar Tomoya Isobe Justyna Rak Iwo Kucinski Melania Barile Natalie A. Webster Maria Eleftheriou Rebecca Hannah Malgorzata Gozdecka George Vassiliou Oliver Rausch Nicola K. Wilson Berthold G öttgens Konstantin Source Type: research
Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease
Leukemia, Published online: 18 July 2023; doi:10.1038/s41375-023-01969-yCorrection: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease (Source: Leukemia)
Source: Leukemia - July 18, 2023 Category: Hematology Authors: Ola Rizq Naoya Mimura Motohiko Oshima Shuji Momose Naoya Takayama Naoki Itokawa Shuhei Koide Asuka Shibamiya Yurie Miyamoto-Nagai Mohamed Rizk Yaeko Nakajima-Takagi Kazumasa Aoyama Changshan Wang Atsunori Saraya Ryoji Ito Masanori Seimiya Mariko Watanabe Source Type: research
Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo
Leukemia, Published online: 18 July 2023; doi:10.1038/s41375-023-01950-9Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo (Source: Leukemia)
Source: Leukemia - July 18, 2023 Category: Hematology Authors: Signe Neldeborg Johannes Frasez Soerensen Charlotte Thornild M øller Marie Bill Zongliang Gao Rasmus O. Bak Kasper Holm Boe Sorensen Mette Nyegaard Yonglun Luo Peter Hokland Magnus Stougaard Maja Ludvigsen Christian Kanstrup Holm Source Type: research
SETBP1 is dispensable for normal and malignant hematopoiesis
Leukemia, Published online: 18 July 2023; doi:10.1038/s41375-023-01970-5SETBP1 is dispensable for normal and malignant hematopoiesis (Source: Leukemia)
Source: Leukemia - July 18, 2023 Category: Hematology Authors: Atsushi Tanaka Koutarou Nishimura Wataru Saika Ayana Kon Yui Koike Hiromi Tatsumi June Takeda Masaki Nomura Weijia Zang Manabu Nakayama Masashi Matsuda Hiromi Yamazaki Miki Fukumoto Hiromi Ito Yasutaka Hayashi Toshio Kitamura Hiroshi Kawamoto Akifumi Taka Source Type: research
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)
Leukemia, Published online: 17 July 2023; doi:10.1038/s41375-023-01938-5Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9) (Source: Leukemia)
Source: Leukemia - July 17, 2023 Category: Hematology Authors: Simone Cesaro Malgorzata Mikulska Hans H. Hirsch Jan Styczynski Sylvain Meylan Catherine Cordonnier Davide Navarro Marie von Lilienfeld-Toal Varun Mehra Francesco Marchesi Caroline Besson Raul Cordoba Masculano Gernot Beutel Herman Einsele Johan Maertens Source Type: research
Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort
Leukemia, Published online: 15 July 2023; doi:10.1038/s41375-023-01958-1Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort (Source: Leukemia)
Source: Leukemia - July 15, 2023 Category: Hematology Authors: Georgia Metzgeroth Laurenz Steiner Nicole Naumann Johannes L übke Sebastian Kreil Alice Fabarius Claudia Haferlach Torsten Haferlach Wolf-Karsten Hofmann Nicholas C. P. Cross Juliana Schwaab Andreas Reiter Source Type: research
Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome
Leukemia, Published online: 14 July 2023; doi:10.1038/s41375-023-01966-1Culture expansion of CAR T cells results in aberrant DNA methylation that is associated with adverse clinical outcome (Source: Leukemia)
Source: Leukemia - July 14, 2023 Category: Hematology Authors: Lucia Salz Alexander Seitz Daniel Sch äfer Julia Franzen Tatjana Holzer Carlos A. Garcia-Prieto Iris B ürger Olaf Hardt Manel Esteller Wolfgang Wagner Source Type: research
Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Leukemia, Published online: 14 July 2023; doi:10.1038/s41375-023-01968-zBlastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies (Source: Leukemia)
Source: Leukemia - July 14, 2023 Category: Hematology Authors: Branko Cuglievan Jeremy Connors Jiasen He Sajad Khazal Sireesha Yedururi Julia Dai Sofia Garces Andres E. Quesada Michael Roth Miriam Garcia David McCall Amber Gibson Dristhi Ragoonanan Demetrios Petropoulos Priti Tewari Cesar Nunez Kris M. Mahadeo Sarah Source Type: research
